VIR-7831 for the Early Treatment of COVID-19 in Outpatients
Clinical trial NCT04545060 · COMPLETED
Trial details
- NCT number
- NCT04545060
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2021-04-08
- Enrollment
- 1057
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.